IT1199972B - Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale - Google Patents

Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Info

Publication number
IT1199972B
IT1199972B IT48055/85A IT4805585A IT1199972B IT 1199972 B IT1199972 B IT 1199972B IT 48055/85 A IT48055/85 A IT 48055/85A IT 4805585 A IT4805585 A IT 4805585A IT 1199972 B IT1199972 B IT 1199972B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
therapy
mental
decay
syndromes
Prior art date
Application number
IT48055/85A
Other languages
English (en)
Other versions
IT8548055A0 (it
IT8548055A1 (it
Inventor
Carlo Scolastico
Gabriele Braglia
Original Assignee
Lpb Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lpb Ist Farm filed Critical Lpb Ist Farm
Publication of IT8548055A0 publication Critical patent/IT8548055A0/it
Priority to IT48055/85A priority Critical patent/IT1199972B/it
Priority to JP60167847A priority patent/JPS61257924A/ja
Priority to US06/760,955 priority patent/US4624946A/en
Priority to ZA855822A priority patent/ZA855822B/xx
Priority to AU46206/85A priority patent/AU564439B2/en
Priority to AT85110904T priority patent/ATE50143T1/de
Priority to EP85110904A priority patent/EP0201623B1/en
Priority to DE8585110904T priority patent/DE3575859D1/de
Priority to CA000495665A priority patent/CA1258233A/en
Publication of IT8548055A1 publication Critical patent/IT8548055A1/it
Application granted granted Critical
Publication of IT1199972B publication Critical patent/IT1199972B/it
Priority to MX9203374A priority patent/MX9203374A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IT48055/85A 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale IT1199972B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
JP60167847A JPS61257924A (ja) 1985-05-08 1985-07-31 脳衰退症状及び精神的衰微を治療するための医薬組成物
US06/760,955 US4624946A (en) 1985-05-08 1985-07-31 Treatment of involutional brain syndromes and mental decay
ZA855822A ZA855822B (en) 1985-05-08 1985-08-01 Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
AU46206/85A AU564439B2 (en) 1985-05-08 1985-08-13 Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
AT85110904T ATE50143T1 (de) 1985-05-08 1985-08-29 Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
EP85110904A EP0201623B1 (en) 1985-05-08 1985-08-29 Pharmaceutical compositions for the treatment of involutional brian syndromes and mental decay
DE8585110904T DE3575859D1 (de) 1985-05-08 1985-08-29 Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
CA000495665A CA1258233A (en) 1985-05-08 1985-11-19 Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
MX9203374A MX9203374A (es) 1985-05-08 1992-06-25 Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Publications (3)

Publication Number Publication Date
IT8548055A0 IT8548055A0 (it) 1985-05-08
IT8548055A1 IT8548055A1 (it) 1986-11-08
IT1199972B true IT1199972B (it) 1989-01-05

Family

ID=11264232

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Country Status (10)

Country Link
US (1) US4624946A (it)
EP (1) EP0201623B1 (it)
JP (1) JPS61257924A (it)
AT (1) ATE50143T1 (it)
AU (1) AU564439B2 (it)
CA (1) CA1258233A (it)
DE (1) DE3575859D1 (it)
IT (1) IT1199972B (it)
MX (1) MX9203374A (it)
ZA (1) ZA855822B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942165A (en) * 1986-02-11 1990-07-17 Advanced Biologics, Inc. Treatment for Alzheimer's disease
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
EP0329053A1 (en) * 1988-02-15 1989-08-23 MAGIS FARMACEUTICI S.p.A. Choline esters of glycerophosphoric acids
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
ITMI20131219A1 (it) * 2013-07-19 2015-01-20 Ricerfarma Srl Colina alfoscerato come inibitore di ialuronidasi
KR101864384B1 (ko) 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
KR101841654B1 (ko) 2017-12-19 2018-03-26 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 신경병증성 통증의 치료, 개선 또는 예방용 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
GB2045612B (en) * 1979-03-27 1983-04-20 Nippon Shoji Kaisha Ltd Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative

Also Published As

Publication number Publication date
US4624946A (en) 1986-11-25
MX9203374A (es) 1992-09-01
ATE50143T1 (de) 1990-02-15
EP0201623B1 (en) 1990-02-07
AU564439B2 (en) 1987-08-13
DE3575859D1 (de) 1990-03-15
IT8548055A0 (it) 1985-05-08
IT8548055A1 (it) 1986-11-08
AU4620685A (en) 1986-11-13
ZA855822B (en) 1986-03-26
JPS61257924A (ja) 1986-11-15
EP0201623A1 (en) 1986-11-20
CA1258233A (en) 1989-08-08
JPH0228580B2 (it) 1990-06-25

Similar Documents

Publication Publication Date Title
IT8027029A0 (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
EP0151989A3 (en) Means for the treatment of cardiac diseases
IT1199972B (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
IT8467950A0 (it) Procedimento e dispositivo per il trattamento del plasma sanguigno
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
DE3879709D1 (de) Platin-arzneimittel.
IT8647656A0 (it) Combinazione di analgesico centrale ed adenina per il trattamento analgesico del corpo umano o animale e composizione farmaceutica che la contiene
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
DK222988D0 (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
DE59003111D1 (de) Arzneimittel und ihre Verwendung zur Behandlung von Parasitosen.
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
SU1473139A1 (ru) Средство, повышающее общую устойчивость организма
IT8520241A0 (it) Composizioni farmaceutiche per il trattamento delle turbe cerebrovascolari e del cervello anziano.
DE69118847T2 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus